Israël - anglais - Ministry of Health

abic marketing ltd, israel - olanzapine - film coated tablets - olanzapine 7.5 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva® is indicated for the management of the manifestations of psychotic disorders. olanzapine teva® is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment olanzapine teva® is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder. the combination of olanzapine teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

Israël - anglais - Ministry of Health

abic marketing ltd, israel - olanzapine - film coated tablets - olanzapine 10 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva is indicated for the management of the manifestations of psychotic disorders. olanzapine teva is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment olanzapine teva is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of olanzapine teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

Israël - anglais - Ministry of Health

abic marketing ltd, israel - olanzapine - film coated tablets - olanzapine 5 mg - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva® is indicated for the management of the manifestations of psychotic disorders. olanzapine teva® is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment olanzapine teva® is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder. the combination of olanzapine teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

Israël - anglais - Ministry of Health

abic marketing ltd, israel - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - etoposide - etoposide - hodgkin's disease. malignant (non-hodgkin's) lymphomas, especially of the histiocytic variety.acute non-lymphocytic leukemia. management of refractory testicular tumors and of small cell lung cancer.

Israël - anglais - Ministry of Health

abic marketing ltd, israel - lamivudine as anhydrous; zidovudine - tablets - zidovudine 300 mg; lamivudine as anhydrous 150 mg - zidovudine - zidovudine - antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection.

Israël - anglais - Ministry of Health

abic marketing ltd, israel - lamivudine - tablets - lamivudine 100 mg - lamivudine - lamivudine - lamivudine is indicated for the treatment of chronic hepatitis b associated with the evidence of hepatitis b viral (hbv) replication and active liver inflammation in aduls and also in children and adolescents aged 2 to 17 years old.

Israël - anglais - Ministry of Health

abic marketing ltd, israel - vinblastine sulfate - solution for injection - vinblastine sulfate 1 mg / 1 ml - vinblastine - vinblastine - vinblastine has proved effective in the treatment of the following neoplasms, either alone or in conjunction with other oncolytic drugs:frequently responsive malignancies :• generalized hodgkin's disease (stages iii and iv, ann arbor modification of rye staging system)• non-hodgkin's lymphoma: - reticulum-cell sarcoma - lymphosarcoma• mycosis fungoides.• neuroblastoma.• histiocytosis x.less frequently responsive malignancies :• choriocarcinoma resistant to other chemotherapeutic agents.• embryonal carcinoma of the testis.• carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.

Israël - anglais - Ministry of Health

abic marketing ltd, israel - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg/ml - oxaliplatin - oxaliplatin - oxaliplatin in combination with 5- fluorouracil (5-fu) and folinic acid (fa) is indicated for : - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour. - treatment of metastatic colorectal cancer.oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first-line treatment of patients with metastatic pancreatic adenocarcinoma (based on nccnguidelines, version 2.2014).

Israël - anglais - Ministry of Health

abic marketing ltd, israel - risedronic acid as sodium - tablets - risedronic acid as sodium 35 mg - risedronic acid - risedronic acid - treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. treatment of osteoporosis in men at high risk of fracture.

Israël - anglais - Ministry of Health

abic marketing ltd, israel - betahistine dihydrochloride - tablets - betahistine dihydrochloride 16 mg - betahistine - betahistine - meniere's syndrom. symptomatic treatment of peripheral vertigo.